204 related articles for article (PubMed ID: 2466394)
1. CSF monoamine metabolites in patients and controls: support for a bimodal distribution in major affective disorders.
Westenberg HG; Verhoeven WM
Acta Psychiatr Scand; 1988 Nov; 78(5):541-9. PubMed ID: 2466394
[TBL] [Abstract][Full Text] [Related]
2. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
Blennow K; Wallin A; Gottfries CG; Månsson JE; Svennerholm L
J Neural Transm Park Dis Dement Sect; 1993; 5(1):5-15. PubMed ID: 7679905
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cerebrospinal fluid monoamine metabolite levels in dominant-aggressive and non-aggressive dogs.
Reisner IR; Mann JJ; Stanley M; Huang YY; Houpt KA
Brain Res; 1996 Apr; 714(1-2):57-64. PubMed ID: 8861609
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
[TBL] [Abstract][Full Text] [Related]
5. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
Vaughn DM; Smyth GB; Whitmer WL; Satjawatcharaphong C
Vet Res Commun; 1989; 13(3):237-49. PubMed ID: 2476887
[TBL] [Abstract][Full Text] [Related]
6. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
7. CSF monoamine metabolites in relation to the diagnostic interview for borderline patients (DIB).
Chotai J; Kullgren G; Asberg M
Neuropsychobiology; 1998 Nov; 38(4):207-12. PubMed ID: 9813458
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.
Blennow K; Wallin A; Gottfries CG; Karlsson I; Månsson JE; Skoog I; Wikkelsö C; Svennerholm L
Eur Neuropsychopharmacol; 1993 Mar; 3(1):55-61. PubMed ID: 7682460
[TBL] [Abstract][Full Text] [Related]
9. Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.
Kishida I; Aklillu E; Kawanishi C; Bertilsson L; Agren H
Neuropsychopharmacology; 2007 Oct; 32(10):2143-51. PubMed ID: 17299512
[TBL] [Abstract][Full Text] [Related]
10. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.
Janssens J; Atmosoerodjo SD; Vermeiren Y; Absalom AR; den Daas I; De Deyn PP
Neurochem Int; 2019 Sep; 128():154-162. PubMed ID: 31034914
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
De Bellis MD; Geracioti TD; Altemus M; Kling MA
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
[TBL] [Abstract][Full Text] [Related]
12. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
[TBL] [Abstract][Full Text] [Related]
13. Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes.
Salomon RM; Kennedy JS; Johnson BW; Urbano Blackford J; Schmidt DE; Kwentus J; Gwirtsman HE; Gouda JF; Shiavi RG
Neuropsychopharmacology; 2005 Nov; 30(11):2082-91. PubMed ID: 15856079
[TBL] [Abstract][Full Text] [Related]
14. CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity.
Kaye WH; Ballenger JC; Lydiard RB; Stuart GW; Laraia MT; O'Neil P; Fossey MD; Stevens V; Lesser S; Hsu G
Am J Psychiatry; 1990 Feb; 147(2):225-9. PubMed ID: 1689122
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers.
Jönsson EG; Nöthen MM; Gustavsson JP; Neidt H; Bunzel R; Propping P; Sedvall GC
Psychiatry Res; 1998 Jun; 79(1):1-9. PubMed ID: 9676821
[TBL] [Abstract][Full Text] [Related]
16. Monoamine metabolites in cerebrospinal fluid during and after acute cerebral ischemia.
Tang HZ; Lu XF; Wang KJ; Ouyang S; Huang YQ
Mol Chem Neuropathol; 1989 Apr; 10(2):77-85. PubMed ID: 2472800
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid 5-hydroxyindolacetic acid correlates directly with negative affective intensity, but not affective lability, in human subjects.
Coccaro EF; Boparai A; Lee R
Int J Neuropsychopharmacol; 2013 Mar; 16(2):261-9. PubMed ID: 22475556
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis.
Andreou D; Söderman E; Axelsson T; Sedvall GC; Terenius L; Agartz I; Jönsson EG
Psychiatry Res; 2015 Sep; 229(1-2):497-504. PubMed ID: 26142836
[TBL] [Abstract][Full Text] [Related]
19. CSF concentration gradients of monoamine metabolites in patients with hydrocephalus.
Malm J; Kristensen B; Ekstedt J; Wester P
J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1026-33. PubMed ID: 7522267
[TBL] [Abstract][Full Text] [Related]
20. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]